These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15509046)

  • 21. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiology casebook. Congenital toxoplasmosis: a case report.
    Pan J; Carey BE
    J Perinatol; 1998; 18(6 Pt 1):489-91. PubMed ID: 9848769
    [No Abstract]   [Full Text] [Related]  

  • 23. Central nervous system toxoplasmosis in adult Ethiopians.
    Amogne W; Teshager G; Zenebe G
    Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of adverse reactions of spiramycin versus pyrimethamine/sulfadiazine treatment of toxoplasmosis in pregnancy: is spiramycin really the drug of choice for unproven infection of the fetus?
    Prasil P; Sleha R; Kacerovsky M; Bostik P
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2215377. PubMed ID: 37217458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
    Pelloux H; Fricker-Hidalgo H; Pons JC; Bost-Bru C; Brenier-Pinchart MP; Jouk PS; Ambroise-Thomas P
    Arch Pediatr; 2002 Feb; 9(2):206-12. PubMed ID: 11915504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Postnatal therapy for congenital toxoplasmosis: a comparison of 2 different treatment approaches].
    Pohl-Schickinger A; Feiterna-Sperling C; Weizsäcker K; Bührer C
    Z Geburtshilfe Neonatol; 2012 Apr; 216(2):73-6. PubMed ID: 22517047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?
    Petersen E; Schmidt DR
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):175-82. PubMed ID: 15482110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancytopenia in a patient given pyrimethamine and sulphamethoxidiazine during pregnancy.
    Pajor A
    Arch Gynecol Obstet; 1990; 247(4):215-7. PubMed ID: 2221996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New perspectives in the chemoprophylaxis of toxoplasmosis.
    Piens MA; Garin JP
    J Chemother; 1989 Feb; 1(1):46-51. PubMed ID: 2723712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital toxoplasmosis: prenatal diagnosis, treatment and postnatal outcome.
    Friedman S; Ford-Jones LE; Toi A; Ryan G; Blaser S; Chitayat D
    Prenat Diagn; 1999 Apr; 19(4):330-3. PubMed ID: 10327137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital toxoplasmosis in a neonate with significant neurologic manifestations.
    Chuang YC; Chen JY; Ji DD; Su PH
    J Formos Med Assoc; 2012 Apr; 111(4):232-3. PubMed ID: 22526213
    [No Abstract]   [Full Text] [Related]  

  • 33. Congenital toxoplasmosis, later relapses and treatment.
    Koppe JG; Meenken C
    Acta Paediatr; 1999 Jun; 88(6):586-8. PubMed ID: 10419236
    [No Abstract]   [Full Text] [Related]  

  • 34. Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
    Van Delden C; Hirschel B
    J Infect Dis; 1996 May; 173(5):1294-5. PubMed ID: 8627092
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
    Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [DRESS complicated by hemophagocytic lymphohistiocytosis in an infant treated for congenital toxoplasmosis].
    Rioualen S; Dufau J; Flatres C; Lavenant P; Misery L; Roué JM
    Ann Dermatol Venereol; 2017 Dec; 144(12):784-787. PubMed ID: 28728858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of congenital toxoplasmosis.
    Wilson CB
    Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
    [No Abstract]   [Full Text] [Related]  

  • 39. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
    Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Congenital toxoplasmosis with hydrocephalus diagnosed in utero: outcome of treatment].
    Cotty F; Carpentier MA; Descamps P; Perrotin F; Richard-Lenoble D
    Arch Pediatr; 1997 Mar; 4(3):247-50. PubMed ID: 9181018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.